Christina Takke Ph.D

Christina Takke Ph.D General Information

Biography

Dr. Christina Takke is a Co-Founder and serves as Managing Partner at V-Bio Ventures. She serves as Board Member at Immagene, Octimet. Previously, Dr. Takke served as Partner at Forbion Capital Partners. She holds a PhD in Developmental Biology, which she obtained under the supervision of Prof. Dr. Campos-Ortega at the Institute of Development Biology of the University of Cologne. After her studies, she gained experience in working with biotech startup companies at Bio-Gen-Tec-NRW in Cologne, Germany, a regional development organization for the biotechnology industry. She evaluated business proposals and assisted the young biotech companies in the fundraising process. She joined the ABN AMRO Capital Life Sciences team as an analyst in 2000. Following this assignment she became Principal before being promoted to Partner. At Forbion She is responsible for scouting and analysis of new investment opportunities as well as general deal execution. She currently serves on the supervisory boards of Forbion's portfolio companies Amakem, arGEN-X, and Pieris. She also serves on the boards of Confo Therapeutics and Syndesi Therapeutics. In recent years she served on the board of Bioceros, and she was closely involved with GlycArt as a Board Observer (sold to Roche in 2005).